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Backgrmm~ We have immm~my dem,.,m+,,,~ed m-vain that mhefmckmmc 
(ATI-q aJrtsnal trireme +,,~, sour¢l as it expanencas meclwnmal dmmlmon. 
Me~floo~: TO fodl~r cbaraclenze acoustic + v ~  (AE) pmllems and 
to ~;y  tf AlE occur m-v~vo at the ~e of begoon a n ~  (BA), 24 
human atonal speomens oblamed post-mort~ and 8 ATH asd conlrel at. 
tenes m~wNo (n~zJswme) were evaluated Artones were ~ lo BA wflh 
s,~naneous moo ing  o( AlE usn~ a ~ i~=eele¢l~ ~a,~- 
dm+-e+. The recorded +~,-,~Is were m-~ized m IM Imme domain using we.,mCet 
teG-.-,Cmes and m lhe frequency domain using Fourier t,~+%-,~p+as, and
chamctmzzed a,~:,+~G.-~j m tbe t~e of ,~_ _,c~J trauma using K,+,~.+,-.+,+ neural 
rmtwork ~ 
P.est.dls: Vascular AIE were demormtraled to occur be;-,~,m~,-+ 30 and 5000 
Hz+ Umng q~m:trograms wilh Koh+.-,~ dasmfmaZton, lhe sounds were char- 
aclenzed as no~eeless, plaque Iraclzae aml lasrlng. The io-vwo dala i+~¢afe 
fewer ex1~-,~us r:,~,~-,as nd 1ha same AE ~ as ,~-~-,~d in ff~e + 
v~ro s~dms. Tean.g m ~ w~ rela1~ely Ion9 (0.4-1,0S) ~;~r+'  
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Conctus~n: We have demonstrated mat vascular ecous~ emtssk~ 
eccur fogo~ng amemma mjury bom m-vitro and m-~vo. Wavefo~n ar~/m 
helps to ~ r  dL~bngutsh normal from pat t~ vascular iojury. ~ data 
supparl the ~- ,c~ of ush'Kj a¢ous~ em=sions as a meens of mor~ortng 
and optin'nzing balloon anojol~asty 
Mechanistically. while it is unlikely that CK elevation prevents vascular 
renanowing per se. myocardial necrosis impairs the clinical manifestation of 
restenosis, thereby reducing the need for ischemia-driven "l V'R. 
Conclusion: In the EPIC study, patients with pariprocedural MI were less 
likely to develop clinical restenosis as measured by the need for TVR at 3 
years. This novel finding (1) highlights a mechanism for potential discordance 
between anglographic and clinical measures of restenosis, and (2) has im- 
plications for future clinical trials, as therapies which reduce periprocedurat 
MI may be associated wit,1 a perceived excess of restenosis when moasured 
by the need for TVR+ 
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